
    
      This is a crossover study that consists of a 2-week placebo run-in period, then a first
      3-week treatment period, then a 2-week washout period, and then a second 3-week treatment
      period. Participants will be randomized to treatment with either montelukast and placebo or
      budesonide and placebo. The duration of treatment is 6 weeks.
    
  